People 75-years and older without cardiovascular disease who took the statin, pravastatin (Pravachol, 40 mg/day), to lower cholesterol were 34% more likely to have died during the 8 year study than people of the same age not taking a statin although the difference did not quite reach statistical significance.
(There was a 7% chance that the difference between the two groups was due to random chance, but this is close enough for me.)
There were 92 deaths in the pravastatin group versus 65 deaths in the non-statin group.
At the very least this means that pravastatin (Pravachol) provides no benefit to people of this age, and at worst, it means that pravastatin (Pravachol) increases the risk of death considerably.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.